| Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study |
|
Journal of clinical oncology: official journal of the American Society Clinical Oncology |
Myelodysplastic Syndromes (MDS) |
| Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis |
|
Leukemia |
Myelodysplastic Syndromes (MDS) |
| Young Enough to Undergo Allogeneic Transplantation for Myelodysplastic Syndromes?: Considering the Results of the Medicare Coverage With Evidence Development Study |
|
JAMA Oncology |
Myelodysplastic Syndromes (MDS) |
| Lowering the boom on lower-risk myelodysplastic syndromes |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Monitoring and treatment of MDS in genetically susceptible persons |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Genetic predisposition to MDS: diagnosis and management |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion |
|
Annals of Hematology |
Myelodysplastic Syndromes (MDS) |
| DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes |
|
Blood Advances |
Myelodysplastic Syndromes (MDS) |
| The evolving role of next generation sequencing in myelodysplastic syndromes |
|
British Journal of Haematology |
Myelodysplastic Syndromes (MDS) |
